| LANTHEUS HLDGS DL-,01 |
| USA |
| Gesundheit |
| US5165441032 / A117UE |
| 0L8 (Frankfurt) / LNTH (NASDAQ) |
| FRA:0L8, ETR:0L8, 0L8:GR, NASDAQ:LNTH |
| - |
| https://www.lantheus.com/ |
|
Lantheus Holdings, Inc. is a leading radiopharmaceutical-focused company that develops, manufactures, and commercializes diagnostic and therapeutic products to assist clinicians in diagnosing and treating heart disease, cancer, and other conditions w..
>Volltext.. |
| 5779.65 Mio. EUR |
| 5889.85 Mio. EUR |
| 1332.61 Mio. EUR |
| 318.57 Mio. EUR |
| 240.49 Mio. EUR |
| 3.63 EUR |
| 539.32 Mio. EUR |
| 429.71 Mio. EUR |
| - |
| 1.5 |
| -5.79% |
| 2.73% |
| - |
| - |
| - |
| - |
| LANTHEUS |
| 23.05.26 |
|
||||
|
||||
|